ANG Lifesciences India's board is all set to invest in the Equity Shares and Redeemable Cumulative Preference Shares of Baddi Agro. Consequent to the acquisition of 51% Equity stake by the company, Baddi Agro will become the subsidiary company of ANG Lifesciences India. The object of the said acquisition is to expand its business activities for manufacturing of Menthol API Derivative and other related products. The company's Board of Directors in their meeting held on November 8, 2021 had decided the same.
ANG Lifesciences India, incorporated in the year 2006, started with the business of manufacturing and marketing of finished pharmaceutical formulation in a dosage form of Sterile Dry Powder Injection Vial.
